Holen Sie sich die Stockscreener-App
22.25
1.81%
-0.41
Handel nachbörslich:
22.25
Schlusskurs vom Vortag:
$22.66
Offen:
$22.89
24-Stunden-Volumen:
2.24M
Relative Volume:
0.65
Marktkapitalisierung:
$4.11B
Einnahmen:
$637.78M
Nettoeinkommen (Verlust:
$239.40M
KGV:
18.68
EPS:
1.1909
Netto-Cashflow:
$307.21M
1W Leistung:
-1.11%
1M Leistung:
-8.70%
6M Leistung:
-66.81%
1J Leistung:
-57.70%
1-Tages-Spanne:
$21.98
$23.28
1-Wochen-Bereich:
$20.55
$23.35
52-Wochen-Spanne:
$20.55
$76.51
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
22.25 | 3.89B | 637.78M | 239.40M | 307.21M | 1.1909 |
VEEV
Veeva Systems Inc
|
159.09 | 24.73B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
49.53 | 7.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
46.04 | 8.71B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
81.36 | 6.59B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
22.43 | 4.12B | 1.10B | 112.09M | 283.19M | 0.6096 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2026-02-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Herabstufung | Goldman | Neutral → Sell |
| 2025-07-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Insider Selling: Doximity (NYSE:DOCS) Insider Sells 2,427 Shares of Stock - MarketBeat
AI Disruption Jitters and Insider Sales Might Change The Case For Investing In Doximity (DOCS) - simplywall.st
Doximity (DOCS) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Doximity interim PFO Sitaram sold $51k in DOCS stock - Investing.com
Doximity (NYSE: DOCS) interim PFO sells shares to cover option taxes - Stock Titan
Here is Why Doximity (DOCS) Still Appears Attractive - Insider Monkey
Doximity, Inc. (NYSE:DOCS) Q4 2025 Earnings Call Transcript - MSN
Can Doximity (DOCS) Turn Its Physician-Focused AI Ecosystem Into Durable Financial Strength? - Yahoo Finance
Is Doximity (NYSE:DOCS) Gaining Traction on The Russell 1000 Index? - Kalkine Media
DOCS Maintained by Keybanc -- Price Target Lowered to $30 - GuruFocus
Assessing Doximity (DOCS) Valuation After Soft Guidance And Rising AI Competition Concerns - Yahoo Finance
KeyCorp Issues Pessimistic Forecast for Doximity (NYSE:DOCS) Stock Price - MarketBeat
Doximity (DOCS) Slid on Concerns Over AI Disruption - Insider Monkey
KeyBanc Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $30 - Moomoo
Sentiment Review: Is Doximity Inc stock a hidden gemWeekly Market Summary & Weekly Market Pulse Updates - baoquankhu1.vn
Doximity, Inc. $DOCS Shares Sold by Baillie Gifford & Co. - MarketBeat
Could Anthropic Managed Agents Pressure The Doximity SaaS Business Model - Yahoo Finance
Is Doximity (DOCS) one of the stocks set to explode in the next 3 years? - MSN
VIP Mid Cap Portfolio's Doximity Inc(DOCS) Holding History - GuruFocus
Affiliate (DOCS) Form 144: Option-exercise sale handled by Morgan Stanley (DOCS) - Stock Titan
Doximity, Inc. Hits New 52-Week Low at $21.66 Amid Declining Stock Performance - Markets Mojo
Doximity, Inc. (DOCS) Stock forecasts - Yahoo Finance UK
Is Doximity Inc (DOCS) a Bargain After 3.2% Drop? GF Value Says Undervalued - GuruFocus
Goldman Sachs Lowers Price Target for Doximity (DOCS) to $28 | D - GuruFocus
Is Doximity (DOCS) One of the Stocks Set to Explode in the Next 3 Years? - Insider Monkey
Doximity (NYSE:DOCS) Given New $28.00 Price Target at The Goldman Sachs Group - MarketBeat
Goldman Sachs Maintains Doximity(DOCS.US) With Hold Rating, Maintains Target Price $28 - Moomoo
Evercore ISI Group downgrades Doximity (DOCS) - MSN
Doximity, Guidewire Software, Intuit, PagerDuty, and Health Catalyst Shares Plummet, What You Need To Know - Yahoo Finance
Goldman Sachs Maintains Doximity(DOCS.US) With Hold Rating, Cuts Target Price to $28 - Moomoo
15 Stocks Set to Explode in the Next 3 Years - Insider Monkey
A Look Back at Vertical Software Stocks’ Q4 Earnings: Doximity (NYSE:DOCS) Vs The Rest Of The Pack - Yahoo Finance
Doximity (NYSE:DOCS) Sets New 52-Week Low Following Analyst Downgrade - MarketBeat
Doximity stock hits 52-week low at 21.81 USD By Investing.com - za.investing.com
Doximity stock hits 52-week low at 21.81 USD - Investing.com
Doximity (NYSE:DOCS) Downgraded to "In-Line" Rating by Evercore - MarketBeat
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Coinbase Global, Diamondback Energy, Deere, Doximity, Dutch Bros., Johnson & Johnson, Robinhood Markets, Verizon and More - AOL.com
Doximity (NYSE:DOCS) Lowered to Strong Sell Rating by Zacks Research - MarketBeat
Evercore Downgrades Doximity(DOCS.US) to Hold Rating, Cuts Target Price to $25 - Moomoo
Evercore ISI cuts Doximity stock rating on slower market growth By Investing.com - Investing.com India
Evercore ISI cuts Doximity stock rating on slower market growth - Investing.com
Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year? - MSN
How The Doximity (DOCS) Investment Story Is Shifting As Valuation And AI Expectations Reset - Yahoo Finance
Doximity’s SaaS Pivot And AI Tools Versus Its Recent Share Slump - Yahoo Finance
Doximity (DOCS) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Doximity: Clinician Network Leader - TradingView — Track All Markets
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo Finance
Doximity IPO: Everything you need to know about Doximit - FOREX.com
Doximity, Inc. (DOCS) stock price, news, quote and history - Yahoo Finance UK
Doximity, Inc. (DOCS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Doximity Sits 70% Below Its 52-Week High With 300,000 AI Users and Zero AI Revenue - TIKR.com
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):